US Broker Ratings

Mineralys Therapeutics (MLYS) Stock Analysis: Uncovering Growth Potential in the Biotech Sector

Mineralys Therapeutics, Inc. (MLYS) is drawing significant attention in the biotechnology space as it continues to make strides in the development of innovative treatments for cardiorenal..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Exploring a 25% Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG) stands as a compelling opportunity within the Healthcare sector, particularly in the Medical Care Facilities industry. With a market capitalization..

BioLife Solutions, Inc. (BLFS) Stock Analysis: A Compelling 20.96% Potential Upside in the Thriving Cell and Gene Therapy Sector

BioLife Solutions, Inc. (NASDAQ: BLFS) is making waves in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $1.27..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 23.97% Potential Upside in the Non-Opioid Pain Management Sector

Pacira BioSciences, Inc. (NASDAQ: PCRX), a prominent player in the healthcare sector, specializes in developing and marketing non-opioid pain management and regenerative health solutions. With a..

NeoGenomics, Inc. (NEO) Stock Analysis: Growth Potential amid Positive Analyst Consensus

NeoGenomics, Inc. (NEO) stands out in the healthcare sector with its specialized focus on diagnostics and research, particularly in cancer-focused testing laboratories. As the company navigates..

Innoviva, Inc. (INVA) Stock Analysis: A Bold 74% Upside Potential for Biotech Investors

Innoviva, Inc. (NASDAQ: INVA) stands out in the biotechnology sector with a remarkable potential upside of 74.41%, according to analyst ratings. With a market capitalization of..

Harrow, Inc. (HROW) Stock Analysis: Eyeing a 99.69% Upside in the Rapidly Growing Eyecare Sector

Harrow, Inc. (HROW) is making waves in the healthcare sector, specifically within the niche of ophthalmic pharmaceuticals. Founded in 1998 and headquartered in Nashville, Tennessee, the..

Travere Therapeutics (TVTX) Stock Analysis: A 20% Upside Potential in the Biotech Arena

Travere Therapeutics, Inc. (NASDAQ: TVTX), a notable player in the biotechnology sector, has caught the attention of investors with its promising growth trajectory and substantial upside..

Biohaven Ltd. (BHVN) Stock Analysis: A 440% Upside Potential in the Biotech Sector

For investors with an appetite for high-risk, high-reward opportunities, Biohaven Ltd. (NASDAQ: BHVN) presents an intriguing proposition. This biotech company, headquartered in New Haven, Connecticut, has..

Omnicell, Inc. (OMCL) Stock Analysis: Exploring a 28.59% Potential Upside in Healthcare Innovation

Omnicell, Inc. (NASDAQ: OMCL) stands as a compelling player within the healthcare sector, particularly in the health information services industry. With a market capitalization of $1.65..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Impressive Revenue Growth and a Promising 23.55% Upside

ANI Pharmaceuticals, Inc. (NYSE: ANIP) is gaining attention in the healthcare sector with its robust performance metrics and promising analyst ratings, making it a compelling choice..

Dynavax Technologies Corp (DVAX) Investor Outlook: Exploring a 106.52% Potential Upside

Dynavax Technologies Corporation (NASDAQ: DVAX) stands out in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $1.3..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 40.49% Potential Upside in the Healthcare Sector

UFP Technologies, Inc. (NASDAQ: UFPT) is making waves in the healthcare sector, capturing investor attention with a compelling potential upside of 40.49%. With a market capitalization..

MannKind Corporation (MNKD): Analyst Consensus Signals Strong Upside Potential

MannKind Corporation (MNKD) has been capturing the attention of investors with its promising pipeline and recent developments in the biopharmaceutical sector. Specializing in endocrine and orphan..

Tarsus Pharmaceuticals, Inc. (TARS) Investor Outlook: A Biotech with Potential 15.74% Upside

For investors seeking opportunities in the healthcare sector, Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) presents an intriguing proposition. This Irvine, California-based biotechnology company is making waves with..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a 43% Potential Upside in the Healthcare Sector

Pulse Biosciences, Inc (NASDAQ: PLSE), a prominent player in the healthcare sector, has been capturing the attention of investors with its innovative bioelectric medicine solutions. With..

Viridian Therapeutics, Inc. (VRDN) Investor Outlook: Assessing a 40.60% Upside Potential in the Biotech Sector

Viridian Therapeutics, Inc. (VRDN), a burgeoning player in the biotechnology sector, is capturing investor attention with a remarkable potential upside of 40.60%, as indicated by the..

Wave Life Sciences Ltd. (WVE): Investor Outlook Highlights 180% Potential Upside in Biotechnology

Wave Life Sciences Ltd. (WVE), a pioneer in the biotechnology sector, is garnering attention from investors with a compelling potential upside of 180.85%. As a clinical-stage..

89bio, Inc. (ETNB) Stock Analysis: A Healthcare Biotech with Over 100% Potential Upside

In the ever-evolving landscape of biotechnology, 89bio, Inc. (NASDAQ: ETNB) presents itself as an intriguing prospect for investors with a taste for high-risk, high-reward opportunities. With..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Exploring Investor Confidence Amid Strong Free Cash Flow

Pediatrix Medical Group, Inc. (NYSE: MD), a key player in the healthcare sector, has carved out a niche within the medical care facilities industry in the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds